These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8258234)

  • 1. Anti-Sm: its predictive value in systemic lupus erythematosus.
    Janwityanuchit S; Verasertniyom O; Vanichapuntu M; Vatanasuk M
    Clin Rheumatol; 1993 Sep; 12(3):350-3. PubMed ID: 8258234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.
    Sánchez-Guerrero J; Lew RA; Fossel AH; Schur PH
    Arthritis Rheum; 1996 Jun; 39(6):1055-61. PubMed ID: 8651971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoblotting profiles in 55 systemic lupus erythematosus sera lacking precipitating antibodies to extractable nuclear antigens.
    Meyer O; Bourgeois P; Aeschlimann A; Haim T; Mery JP; Kahn MF
    Ann Rheum Dis; 1989 Jul; 48(7):594-9. PubMed ID: 2789021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-dsDNA and Sm autoantibodies in systemic lupus erythematosus.
    Martínez-Cordero E; Martínez-Miranda E; Negrete-García MC; Padilla A; Aguilar León DE
    Clin Rheumatol; 1992 Sep; 11(3):341-5. PubMed ID: 1458781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3.
    Flechsig A; Rose T; Barkhudarova F; Strauss R; Klotsche J; Dähnrich C; Schlumberger W; Enghard P; Burmester GR; Hiepe F; Biesen R
    Clin Exp Rheumatol; 2017; 35(4):598-606. PubMed ID: 28281463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibody profiles in relation to specific disease manifestations of systemic lupus erythematosus.
    Swaak AJ; Huysen V; Nossent JC; Smeenk RJ
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):82-94. PubMed ID: 2203596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibodies in systemic lupus erythematosus.
    Fong KY; Boey ML; Howe HS; Feng PH
    Med J Malaysia; 1989 Jun; 44(2):151-5. PubMed ID: 2626124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiotypic independency of anti-dsDNA and anti-Sm antibodies in SLE sera.
    Kubota T; Dang H; Takei M; Miyasaka N; Kanai Y; Talal N
    Clin Exp Rheumatol; 1989; 7(5):572-3. PubMed ID: 2591135
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters.
    Barada FA; Andrews BS; Davis JS; Taylor RP
    Arthritis Rheum; 1981 Oct; 24(10):1236-44. PubMed ID: 6975630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of antibodies to Sm (Smith) and RNP (ribonucleoprotein) in patients with rheumatic diseases.
    Tsay GJ; Su CB; Chen TY; Lin CS
    Taiwan Yi Xue Hui Za Zhi; 1984 May; 83(5):436-43. PubMed ID: 6332172
    [No Abstract]   [Full Text] [Related]  

  • 12. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus.
    Yasuma M; Takasaki Y; Matsumoto K; Kodama A; Hashimoto H; Hirose S
    J Rheumatol; 1990 Apr; 17(4):469-75. PubMed ID: 2348425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of anti-Sm antibodies in systemic lupus erythematosus.
    Beaufils M; Kouki F; Mignon F; Camus JP; Morel-Maroger L; Richet G
    Am J Med; 1983 Feb; 74(2):201-5. PubMed ID: 6600581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Sm and RNP. Prognosticators of disease involvement.
    Munves EF; Schur PH
    Arthritis Rheum; 1983 Jul; 26(7):848-53. PubMed ID: 6603221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus.
    Mahler M; Waka A; Hiepe F; Fritzler MJ
    Arthritis Res Ther; 2007; 9(4):R68. PubMed ID: 17640359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies].
    López-Longo FJ; González Fernández CM; Rodríguez Mahou M; Grau Simó R; Monteagudo Sáez I; Meno García AC; Carreño Pérez L
    Rev Clin Esp; 1997 May; 197(5):329-35. PubMed ID: 9280966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic significance and diagnostic value of lupus autoantibodies.
    Tomer Y; Buskila D; Shoenfeld Y
    Int Arch Allergy Immunol; 1993; 100(4):293-306. PubMed ID: 8481649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
    To CH; Petri M
    Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.